Cited by 12Hormonal and reproductive studiesAdrenal Hormones and DisordersHeart Failure Treatment and Management

Effects of transdermal testosterone on natriuretic peptide levels in women: a randomized placebo-controlled pilot study

Open access
Lin, Eleanor, McCabe, Elizabeth, Newton-Cheh, Christopher, Bloch, Kenneth, Buys, Emmanuel, Wang, Thomas, Miller, Karen K.·2012·Fertility and Sterility

Abstract

Objective To investigate whether testosterone administration alters natriuretic peptide levels in women.Design Three-month, double-blind, randomized, placebo-controlled study.Setting Clinical research center.Patient(s) Fifty-one women with hypoandrogenemia due to hypopituitarism.Intervention(s) Transdermal testosterone (300 μg daily) or placebo patch.Main outcome measure(s) N-Terminal pro-B-type natriuretic peptide (NT-proBNP) levels.Result(s) NT-proBNP levels decreased in the transdermal testosterone group compared with placebo over three months. The difference between groups remained significant after controlling for baseline age, systolic blood pressure, body mass index, and homeostasis model assessment of insulin resistance. Change in NT-proBNP over 3 months was inversely associated with change in free testosterone levels.Conclusion(s) Testosterone administration to women results in decreased natriuretic peptide levels, suggesting that testosterone may be an inverse regulator of the natriuretic peptide system.Clinical trials registration number NCT00027430.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2011.11.001

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The relatively low endogenous testosterone levels in women with PCOS compared with men do not seem to have any major influence on MR-proANP levels.

    “Based on these findings, the relatively low endogenous testosterone levels in women with PCOS compared with men do not seem to have any major influence on MR-proANP levels.”
  • Studies in other populations and a study administering testosterone therapy in women with hypoandrogenemia point to an inverse correlation between NPs and testosterone.

    “Regarding testosterone, studies in other populations and a study administering testosterone therapy in women with hypoandrogenemia point to an inverse correlation between NPs and testosterone (41, 42).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lin, E., McCabe, E., Newton-Cheh, C., Bloch, K., Buys, E., Wang, T., & Miller, K. K.
Affiliations
Harvard University (US)
Corresponding author
Miller, Karen K.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2012-02
Volume
97
Issue
2
Pages
489-493
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2091358616
Cited by
12
References
28
Citations by year
2024: 1 · 2023: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • Procter and Gamble
  • National Institutes of Health
  • U.S. Food and Drug Administration (FD-R-001981)
  • National Heart, Lung, and Blood Institute (K24HL092902)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007028)
  • National Center for Research Resources (M01RR001066, M01-RR01066)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
transdermal testosterone, natriuretic peptides, NT-proBNP, women, hypopituitarism, free testosterone, natriuretic peptide system, insulin resistance, blood pressure
MeSH terms
Administration, Cutaneous, Adult, Analysis of Variance, Androgens, Boston, Double-Blind Method, Female, Humans, Hypopituitarism, Middle Aged, Peptide Fragments, Pilot Projects, Regression Analysis, Testosterone, Time Factors, Biomarkers, Down-Regulation, Treatment Outcome, Natriuretic Peptide, Brain, Hormone Replacement Therapy, Young Adult, Transdermal Patch

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review